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Abstract
Background: In sub-Sahara Africa, more than 60% of all new HIV infections are occurring in women, infants and young
children. Maternal to child transmission is responsible for 90% of childhood HIV infection. Preventing unwanted pregnancy
among HIV positive women is imperative to reduce maternal and infant morbidity and mortality.
Methods: A cross-sectional survey was conducted among 964 HIV positive women in selected 12 health centers of Tigray
region. In this paper, analysis was restricted only for 847 women who were sexually active and non-pregnant. In each health
center the number of study participants was allocated proportionally to the load of HIV positive women in chronic care
clinics. The data were entered into EpiData version 3.1, and cleaned and analyzed using Stata version 11.1. Descriptive
summary of data and logistic regression were used to identify possible predictors using odds ratio with 95% confidence
interval and P-value of 0.05.
Findings: Three hundred ninety four (46.5%) of all HIV positive women had intension to have more children. Three hundred
seventy five (44.3%) were using contraceptive methods at time of survey. Injectable (70.7%) and male condom (47.6%) were
most commonly used type of contraceptives. In the multivariable analysis, women who were urban dwellers (AOR= 2.55;
95% CI: 1.27, 5.02), completed primary education (AOR= 2.27; 95% CI: 1.12, 2.86) and those openly discussed about
contraceptive methods with their husbands or sexual partners (AOR= 6.3; 95% CI: 3.42, 11.76) were more likely to use
contraceptive. Women who have one or more living children were also more likely to use contraceptive compared with
women with no child.
Conclusion: Less than half of women used contraceptive methods. The use of condoms could impact unintended
pregnancies and reduced risks of vertical and sexual transmission. Efforts to increase contraceptive utilization focusing on
the barrier methods should be strengthen in HIV/AIDS chronic care units.
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Background
It is estimated that 33 million people are currently living with
HIV/AIDS worldwide. Sub-Sahara Africa is home of 60% of
people living with HIV/AIDS and more than half of these
population groups are females [1]. Studies estimated that 75% of
HIV positive people are of reproductive age worldwide [2].
According to 2011 Ethiopian Demographic and Health Survey
(EDHS) estimate, the prevalence of HIV in Ethiopia was 1.5%
among the population group of age 15–49 years and he figure
among women was significantly higher (1.9%) than men (1.0%) [3].
Importantly, HIV infection is linked with women’s sexual and
reproductive health, because it is not only transmitted by sexual
contact but also more than half of the 2.6 million new infections
globally were among women [4]. As a result, there is growing
recognition of the reproductive decision faced by HIV infected
individuals. Studies in both developed and developing countries
have suggested that many HIV positive women continue to desire
children despite the knowledge of their HIV status [5,6,7,8].
Hence, meeting women’s sexual and reproductive health (SRH)
needs ensures women have control over their reproductive lives, as
well as contributes to public health by reducing maternal and
infant mortality and morbidity [9].
Unintended pregnancy is a common problem in both HIV-
positive and HIV negative women. A study conducted in
Swaziland has indicated that 69.2% of women reported that their
recent pregnancy was unintended with no difference in sero-status.
However, the rate of unwanted pregnancy was found to be
significantly higher in HIV-positive women than their counter-
parts (20.7% versus 13.5%) [10]. Previous similar studies indicated
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that the rate of unintended pregnancy is also high among HIV-
positive women [11,12]. Enabling women living with HIV to
avoid unintended pregnancy can reduce vertical transmission of
HIV and maternal mortality associated with HIV infection [13].
As a result, a component of the World Health Organization
(WHO) comprehensive strategy 2011–2015 for Prevention of
Mother-to-Child Transmission (PMTCT) is to increase contra-
ceptive use among HIV positive women who wish to use it [14].
However, the prevalence of contraceptive utilization level varies in
different settings with low ceiling [10,11,15–20].
Studies have reported that most women have preferred condom
as method of pregnancy prevention. In studies, the most common
type of contraceptive used was condom among 7% to 90% of
women [15–21]. On the other hand, a study in South Africa
reported that most women were using short acting method,
primarily injectable (70.2%) [11]. Other studies demonstrated that
utilization of injectable (4.1%) and pills (3.3%) was found to be low
in rural Uganda [17] for different perceived reasons by women
[21]. HIV positive women have different reasons and factors
influencing their contraceptive utilization unlike their negative
counterparts. Open discussion about family planning with health
workers and spouse [18], disclosure of HIV sero-status and
discussion on fertility issue [19], being married and older age of
women [22], were found to be positively associated with current
family planning utilization. In regard to the association between
education and contraceptive utilization among HIV-positive
women, contradicting findings were reported in Uganda and
Kenya [18,23].
Enabling women living with HIV to avoid unintended
pregnancy and use of contraceptive methods reduces vertical
transmission of HIV and further morbidity and mortality of
mothers and children [9]. In particular, contraceptive use averts
19.7% of infections and 13.1% of deaths [24].
In settings where HIV prevalence is high, management of
sexual and reproductive health of HIV-infected women is critical
to reduce HIV transmission and maternal mortality. However,
family planning utilization and factors associated with it have not
been well understood in resource limiting settings like Ethiopia.
Therefore, the main aim of this study was to describe family
planning utilization which will help in estimating the family
planning needs of HIV positive women and which in turn could
help to prepare the necessary resources and flourish programs for
better reproductive health services. The other main purpose of the
current study was addressing the knowledge gap with regard to
factors associated with family planning utilization among HIV
positive women. Understanding the factors benefit in a way that
patients as well as care givers intervene on those factors. This study
is also believed to benefit many concerned stakeholders in decision
making and policy development.
Methods
Study area and period
Tigray region has an estimated total population of 4,664,071, of
which 2,367,032 are females. More than 80% of the population is
estimated to be rural inhabitants [25]. According the regional
health bureau report of 2012, Tigray had 14 hospitals, 205 health
centers and 552 health posts [26].
Antenatal care surveillance data in 2009 reported that the HIV
prevalence in Tigray was 2.2% (5.0% urban and 1.3% rural) [27].
The 2011 EDHS estimated that overall HIV adult prevalence (15–
49 years) to be 1.8% (1.9% among women and 1.0% among men)
[3]. In 2012, the Federal HIV/AIDS Prevention and Control
Office (HAPCO) estimated that there were about 56,900 HIV
positive individuals in the region [28]. HIV prevalence in Tigray
varies widely across zones from 0.4% (Central zone) to 2.2%
(Western) [29].
In the region there were 60 health centers which were
supported by Ethiopian Network of HIV/AIDS Treatment, Care
and Support (ENHAT-CS). All health centers provide services
including HIV prevention, testing, treatment and care and all
family planning methods free-of-charge. Family planning services
include barrier, oral, and injectable contraceptive methods as well
as family planning counseling from a trained family planning
nurse.
This study was conducted at chronic follow up care (both pre-
ART and ART) clinics in 12 ENHAT-CS supported health
centers in Tigray region (Figure 1) from May to June 2013.
Study design
This analysis is based on a cross-sectional survey data of HIV
positive women seeking services at ENHAT-CS supported health
centers in the region. Medical chart was reviewed to confirm HIV
status, ART use history and other medical characteristics of HIV
positive women.
Eligibility criteria
To be eligible to participate in the overall study, women were
required to be 15–49 years of age, attending a chronic follow up
care, competent to give informed consent, and willing to allow
medical record review for the purposes of confirming HIV sero-
status and other medical histories. We considered a woman to be
ART user if she was taking ART at the time of interview. We
considered woman to be pre-ART (not using ART) if she had
never taken ART before.
Sample selection
Twenty percent of ENHAT-CS supported health centers were
selected with simple random sampling technique using lottery
method. The numbers of health centers in each administrative
zone (6 zones of the region) were determined proportionally
considering the total number of ENHAT-CS supported health
centers in each zone. The numbers of study participants in each
health center were determined using proportion to population size
(HIV positive women registered in the health centers). In this case,
the number of women who were HIV positive and were on
chronic follow up care was taken in to account to determine the
number of samples in each health center (Figure 2).
To select each woman in each health center pre-arrival
systematic random sampling technique was used. The first woman
to contact was selected by lottery method after determining the
interval between two study units.
The analysis was restricted to 847 women aged 15–49 years
who were sexually active, and were not pregnant. This was done to
enhance the comparability of findings with other studies investi-
gating reproductive and sexual health among HIV positive
women.
Data collection procedures and enumerators
After confirming eligibility and seeking written informed
consent, participants were asked to complete a 25–35 minute
interviewer-administered questionnaire in local language called
‘‘Tigrenga’’. Approximately 6 women were interviewed daily by a
data collector at each heath center from May to June 2013. Data
collectors were trained women from the local community who had
previous research experience and were holders of Bachelor degree.
Contraceptive Utilization among HIV-Positive Women
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Figure 1. Map of study area (Ethiopia, Tigray region) and location of study health centers.
doi:10.1371/journal.pone.0094682.g001
Figure 2. Schematic presentation of sampling procedure.
doi:10.1371/journal.pone.0094682.g002
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In each health center, nurses with HIV/AIDS related training
reviewed medical records of participants.
Data collection instruments
The questionnaire assessed socio-demographic characteristics,
fertility intentions, fertility history, contraceptive practice, and
sexual history. The survey instrument was developed by organiz-
ing variables from previously conducted researches [10,30,31].
Medical records of HIV positive women were reviewed to confirm
HIV status and other medical history, and to obtain all necessary
clinical data including CD4 cell counts and WHO stage of disease
using data extraction tool (checklist).
Measures and operational definitions
The primary outcome was self-reported contraceptive use at the
time of the survey. Contraceptive utilization refers to use of any form
of either modern or traditional contraceptive methods to avoid or
delay pregnancy. Current use of contraceptive method referred to
respondents who responded positively for use of contraceptive
methods at time of the survey to delay or avoid pregnancy.
Contraceptive method queries included male and female condoms
(restricted to those reporting ‘‘Always’’ use), injections (depome-
droxyprogesterone acetate (DMPA) or norethisterone enantate),
oral contraceptive pills, diaphragm, intrauterine devices (IUD),
female tubal ligation, hysterectomy, and male partner sterilization.
In addition, traditional methods (coitus interrupts and calendar
method) were incorporated as part of the responses in the
questionnaire. In assessing the contraceptive method profile, dual
protection was defined as use of both a barrier contraceptive
method (male condom) and use of a hormonal or permanent
contraceptive method [32].
The explanatory variables were current receipt of ART, age,
education, employment, current sexual partnership, number of
living children, fertility intentions, and HIV clinical variables.
‘‘Sexual intercourse’’ were defined to refer specifically to ‘‘vaginal-
penile penetrative sex between a man and a woman’’. We define
HIV-positive women on chronic care as women who had at least one
visit to the selected pre-ART or ART units for care who may be
receiving ART or not. Fertility intention was defined as HIV positive
women on chronic follow up care would like to have child/
children in the future.
Data quality control, management and analysis
First code was given to the completed questionnaires and then
data were entered into Epidata Version 3.1 database and
transferred to STATA version 11.1 (Stata Corporation, College
Station, TX, USA) statistical packages for analysis.
Pretest of questionnaire was conducted out of study health
centers. Supervisors had checked filled questionnaires and
checklists for consistency, completeness and accuracy on daily
base for all clients. Supportive supervision by investigators was also
rendered for each data collectors and supervisors.
Cleaning of data was done to check the consistency and
completeness of the data set. Frequencies, proportions and
summary statistics were used to describe the study population in
relation to relevant variables. Both bivariable and multivariable
logistic regression were used to identify significant predictors. The
degree of association between independent and dependent
variables was assessed using odds ratio with 95% confidence
interval. Differences in contraceptive use between groups were
reported using Pearson’s chi-square or score test for trends of odds
for categorical variables. After testing for co-linearity [33] and
interaction [34], all covariates with statistically significant associ-
ations in the bivariable analysis were included in multivariable
logistic regression models to obtain adjusted estimates of the
association between covariates and contraceptive use. All statistical
tests were two-sided and considered statistical significant at P value
of 0.05. ArcGIS version 10.0 was used to map study area and
locate health centers.
Ethics statement
Information letters and written consent forms were available in
English and ‘‘Tigrenga’’. Ethical clearance was obtained from the
Institutional Review Board of Mekelle University, College of
Health Sciences. The members of Institutional Review Board were
nominated by the management body of Mekelle University and
consist of experts in the field of subject matter, Medical ethics and
statistics. Permission letters were gained from Tigray regional
health bureau, respective district health offices and health centers.
After explaining the objective and contents of the study, written
consent has been obtained from each respondent or next-of-kin
when the respondent were under 18 years of age. Some of the
study participants were unable to read and write. In this case,
trained interviewers fully explained the purpose, process, benefits,
and risks to all study participants before consent was obtained and
inked index finger print was used as a signature. This consent
procedure was reviewed and approved by Mekelle University
College of Health Sciences Institutional Review Board. The
information collected was purely used for research works and
name of respondents has remained anonymous.
All the interviews with study participants were made with strict
privacy and assuring confidentiality. Each interview was conduct-
ed in a separate room which was prepared for this purpose. The
participants were told that they have the right to either refuse to
participate in the study or withdraw after responding for some of
the questions. Respondents’ name and identity were not recorded,
included and linked in the questionnaire. Data were kept
confidential by locking in boxes with key and by password in the
computer to avoid access of the data by third party. Only card
numbers of the clients were used to review secondary data and link
with the primary data of the clients. Similarly, the names of the
clients have not been reviewed and were not recorded. The
collected data also were not linked with the individual identity at
all level of data processing and analysis.
Results
Of 964 women approached for participation, all consented,
interviewed and underwent medical record review (participation
rate = 100%). Analysis was done for 847 sexually active, non-
pregnant and age 15–49 years of old women.
Socio-demographic characteristics
Majority, 242 (28.6%) of the study participants were in the age
between 30 to 34 years and median age was 30 (Inter quartile
range (IQR) = 27, 35). Three-quarters (75.6%) of the participants
were from urban areas. Of all study participants 92.9% and 91.4%
were found in the ethnic group of ‘‘Tigrie’’ and were followers of
orthodox Christianity, respectively. About three-fifths (58.4%) of
women were illiterate. Housewives, daily laborers and farmers,
each accounted for more than three-fifths (21.3%, 21.6% and
19.4%, respectively) of all occupations of the study participants.
More than two-fifths of the participants were married at the time
of survey. Functional television and radio were present in less than
a third (32.4%) and less than half (44.6%) of the study participants’
house, respectively (Table 1).
Contraceptive Utilization among HIV-Positive Women
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Table 1. Socio demographic characteristics of HIV positive women of reproductive age in Tigray region, northern Ethiopia, 2013.
Characteristics Categories Frequency(n) Percent (%)



















Median = 30, IQR = (27, 35)
Residence Urban 640 75.6
Rural 207 24.4
Ethnicity Tigray 787 92.9
Amhara 53 6.3
Other 7 0.8
Religion Orthodox 774 91.4
Muslim 62 7.3
Other 11 1.3
Level of education No formal education 495 58.4
Primary education 226 26.7
Secondary and above education 126 14.9
Occupation Unemployed 95 11.2
Housewife 180 21.3





Current marital status Currently married to single husband 351 41.4
Currently Partnered (with single sexual partner) 181 21.4
Have more than one sexual partners 315 37.2
Presence of functional Television in the household Yes 274 32.4
No 573 67.7
Presence of functional radio in the household Yes 378 44.6
No 469 55.4
doi:10.1371/journal.pone.0094682.t001
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Medical and reproductive health related profile of the
participants
The proportion of women who had disclosed their sero-status
(45.7%) was significantly higher than those who didn’t (36.0%)
(P = 0.04). Majority of the respondents (786, 92.8%), reported that
their health status was improving. More than half (52.5%) of
women had one or two children. Median time since HIV diagnosis
and duration of ART use were 3.4 years (IQR=1.9, 4.6]) and 2.2
years (IQR=0.4, 3.8), respectively. Almost three-fifths of women
were in WHO stage-I and 85.2% of them had disclosed their HIV
status for someone. More than half (52.8%) had latest CD4 count
.=350 cells/mm3 (Median CD4 count 351 cells/mm3,
IQR=234, 520) (Table 2).
One fifth (80.2%) of the participants were on non-ART
medication/prophylaxis. More than half (52.5%) of women had
one or two children and less than half (46.5%) reported intent to
have more children in the future. Contraceptive utilization
significantly varied with total number of living children women
had (P = 0.0047) and fertility intention (P= 0.010) (Table 2).
Table 2. Medical and reproductive profile of HIV positive women of reproductive age in Tigray region, northern Ethiopia, 2013.
Contraceptive use
Characteristics Categories Frequency(n) % Yes (%) No (%) x2 P-value
HIV status disclosed for anyone Yes 722 85.2 330(45.7) 392(54.3) 0.044@
No 125 14.8 45(36.0) 80(64.0)
Perceived current health status Deteriorating 13 1.5 4(30.8) 9(69.2) 0.6965
$
Same 48 5.7 18(37.5) 30(62.5)
Improving 786 92.8 353(44.9) 433(55.1)
Time since HIV diagnosis (years) ,1 96 11.3 35(36.5) 61(63.5) 0.3649
$
[1–2] 128 15.1 60(46.9) 68(53.1)
(2–3] 144 17.0 64(44.4) 80(55.6)
(3–4] 169 20.0 76(45.0) 93(55.0)
(4–14) 310 36.6 140(45.2) 170(44.8)
Median year 3.3(IQR = 1.9, 4.6) (min 0.0055, max 13.05)
Current WHO clinical stage I 495 58.4 250(50.5) 245(49.5) ,0.001
$
II 147 17.4 61(41.5) 86(58.5)
III/IV 205 24.2 64(31.2) 141(68.8)
Last CD4 count ,200 144 17.0 55(38.2) 89(61.8) 0.7244
$
.= 200–350 256 30.2 127(49.6) 129(50.4)
.= 350 447 52.8 193(43.2) 254(46.8)
Median CD4 count 351 (IQR = 234, 520) (min 0, max 1986)
On ART Yes 720 85.0 321(44.6) 399(55.4) 0.666@
No 127 15.0 54(42.5) 73(57.5)
Duration of ART use (years) 0 (not started) 127 15.0 54(42.5) 73(57.5) 0.4682
$
,1 153 18.1 74(48.4) 79(51.6)
[2–3) 125 14.8 58(46.4) 67(53.6)
[3–4) 116 13.7 52(44.8) 64(55.2)
[4–10) 326 38.5 137(42.0) 189(48.0)
Median year 2.2 (IQR = 0.4, 3.8) (min 0, max 9.28)
On other medication/prophylaxis Yes 679 80.2 296(43.6) 383(55.4) 0.423@
No 168 19.8 79(47.0) 89(53.0)
Total # of living children (n = 829) None 147 17.4 43(29.3) 104(70.7) 0.0047
$
1–2 children 445 52.5 211(47.4) 234(52.6)
3–4 children 207 24.4 98(47.3) 109(52.7)
5–7 children 48 5.7 23(47.9) 25(52.1)
Median # of living children = 2 (IQR = 1,3) (min 0, max 7)
Fertility intentions Yes 394 46.5 193(49.0) 201(51.0) 0.010@




-Trend of odds x2,
min-minimum, max-maximum.
doi:10.1371/journal.pone.0094682.t002
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Prevalence of contraceptive use and types of
contraceptive methods
Almost half of the respondents ever used contraceptive methods
before and after HIV diagnosis. Exactly similar proportion (413,
48.8%) of women had ever used contraceptive methods before and
after HIV diagnosis (Figure 3). At time of survey, overall
contraceptive prevalence was 44.3%. Four hundred sixty two
(54.6%) women had intention to use contraceptive methods in the
future (Figure 4).
Contraceptive method preferences are shown in figure 3 and
4. As shown, the most common type of contraceptive ever used
before and after HIV diagnosis was injectable (86.9% and 74.8%,
respectively). Utilization of male condom has doubled after HIV
diagnosis (before diagnosis = 24.7% and after diagnosis = 47.9%)
while oral contraceptive pill has decreased almost by half after
HIV diagnosis (before diagnosis = 14.3% and after diagno-
sis = 7.3%). Fourteen percent of women had ever used dual
method after HIV diagnosis (Figure 3). At time of survey 86.9%
and almost half (47.6%) of women were using injectable and male
condom, respectively. About 14% of women were using dual
method at the time of survey (Figure 4).
Generally, utilization of permanent methods (tubal ligation and
vasectomy) was very low both before and after HIV diagnosis.
However, hormonal and barrier methods were used commonly
among HIV positive women (Figure 3 and 4).
Determinants of contraceptive use
The unadjusted odds of reporting contraceptive use among
ART users and non-users were not significantly different. Age,
Educational level, occupation, presence of functional radio and
television, number of living children, fertility intention, WHO
clinical stage, latest CD4 count, disclosure of status, counseling
status and open discussion with sexual partner/husband had crude
significant association with contraceptive utilization (Table 3).
In adjusted analyses, there were no significant differences in
contraceptive use by HIV clinical characteristics. Residency,
education, number of living children and open discussion with
sexual partner/husband had significant association with contra-
ceptive use among HIV-positive women.
Urban residents were more likely than their rural counterparts
to report contraceptive use with statistically significant difference
(AOR=2.55; 95% CI: 1.27, 5.02). Primary education
(AOR=2.27; 95% CI: 1.12, 2.86), having one or more living
children, and having open discussion with husband/sexual partner
about contraceptive methods (AOR=6.34; 95% CI: 3.42, 11.76)
and use (AOR=6.34; 95% CI: 3.42, 11.76) remained significantly
associated with contraceptive use (Table 3).
Discussion
In this study, 44.3% of HIV-positive women were using
contraceptive methods at time of survey. This finding is
comparable with other studies, 48% [20] and 43% [16]. In the
same region (Tigray), 46.3% of contraceptive use was reported by
Berhane Y. et al, in 2013 [35]. This is due to the fact that the level
Figure 3. Contraceptive methods ever used before and after HIV diagnosis among HIV positive women of reproductive age in
Tigray region, northern Ethiopia, 2013.
doi:10.1371/journal.pone.0094682.g003
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of sexual activity and knowledge on contraceptive methods in
these study areas are similar [16,20]. However the proportion of
HIV positive women who were using contraceptive methods in
Uganda, 66.4% [15] and 80% [19] and in South Africa, 89.8%
[11] were very high compared to ours. This could be due to high
quality and strong integration of SRH services with ART/HIV
services in these countries [11,15,19]. Low level of contraceptive
utilization by HIV positive women will lead to high rate of
unintended pregnancy, vertical and sexual transmission of the
virus [9]. Attitude of HIV positive women towards contraceptive
utilization as a result of misconception, culture and religious
barriers can lead to low prevalence of contraceptive use [3].
Similarly, structural barriers, like low availability of methods, can
influence utilization of contraceptive methods in this segment of
the population [18].
The proportions of HIV positive women who were using
contraceptive in Uganda, 34% [22], Swaziland, 17.9% [10], and
Uganda, 25% [18], found to be lower than our study participants.
Similarly, other study in Uganda reported that contraceptive
utilization among HIV positive women is very low [17]. The
immediate fertility desire of women in these studies was very high
as it may lower contraceptive utilization [10,17,18,22].
In our study, injectable was the most commonly used type of
contraceptive method which accounts 70.7% of users. This is also
similar with a study conducted in South Africa, 70.2% [11].
Women were interested in using injectable because it can be used
without their partners’ awareness and injectable has less tension
than pills like swallowing and remembering of timing of pills
swallowing [21]. However, utilization of injectable method
reported very low in Uganda, 4.1% [17] and Northern Malawi,
19% [20]. This could be the cost of injectable is high than other
methods in these countries [21] and in Ethiopia, family planning
services are free of charge. A study from Tigray state has
demonstrated that lower proportion (22.7%) of HIV positive
women was using injectable [35]. The study setting from which the
sample was taken could explain this difference. Ours was
conducted in health centers unlike zonal hospital of this study.
In the current study, male condom was used by 47.6% of HIV
positive women. This is slightly comparable with two studies in
Uganda, 54.9% [17] and 39% [19]. However, this was higher
than studies in different parts of the world. Studies in Northern
Malawi, Uganda and France, indicated that 19% [20], 11% [18]
and 31 [16] of HIV positive women were using condom,
respectively. On the other hand, studies in Ethiopia (70%) and
Uganda (90%) reported that higher proportions of women were
using condom [15,35]. In another qualitative study, most women
preferred condom as method of pregnancy prevention since they
concerned about taking additional pills in addition to ART [21].
In our study dual method utilization was 14.1% which is
comparable with other study conducted among HIV clinic clients
in Uganda, 11% [19]. Higher proportions were reported by
studies in Tigray state (Ethiopia) (59.9%) [35] and Uganda, 4%
[15].
Having open discussion with husband/sexual partner about
contraceptive methods remained positively associated with con-
traceptive use. Similar findings were reported by different
researches. HIV disclosure for sexual partner was also associated
with increased fertility desire of women [36,37]. Open discussion
about contraceptive methods with health workers and spouse were
found to be positively associated with current contraceptive
Figure 4. Contraceptive methods used during survey time and future intention among HIV positive women of reproductive age in
Tigray region, northern Ethiopia, 2013.
doi:10.1371/journal.pone.0094682.g004
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utilization [18]. Similarly, a study in HIV clinics indicated that
women who didn’t disclose their HIV status to sexual partners and
women who didn’t discuss on fertility issues were less likely to use
contraception [19].
Though there are wide ranges of factors which affect utilization
of contraceptive methods among HIV positive women, only
individual level factors were addressed in this study. Hence,
considering factors from the service providers’ side [38] and
structural barriers [18] would have been important. In addition,
male clients were not included in the study, which might be
important to consider.
In conclusion, less than half proportion of HIV positive women
were utilizing contraception at time of survey. Educational status,
number of living children and discussion with husband/sexual
partner on contraceptive methods and use, are identified as
independent predictors of contraceptive use among HIV positive
women. Through prevention of unintended pregnancy, integrated
services are likely to benefit maternal and child health, prevent
Table 3. Predictors of family planning utilization among HIV positive women of reproductive age in Tigray region, northern
Ethiopia, 2013.
Contraceptive use
Characteristics Categories Yes No COR(95% CI) AOR(95% CI) P-value
Age (per increase in year) Median 6 SD 3065.68 3167.10 0.94(0.92,0.96)** 0.95(0.90,1.00) 0.049
Residence Urban 321 319 2.85 (2.02, 4.03)** 2.52(1.27,5.02)* 0.008
Rural 54 153 1.00 1.00
Educational Level No formal education 192 303 1.00 1.00
Primary education 121 105 1.82(1.32,2.50)** 2.27 (1.12,2.86)* 0.023
Secondary and above
education
62 64 1.53(1.03,2.27)* 1.01(0.45,2.25) 0.981
Occupation Unemployed 231 231 1.73(1.31,2.28)** 1.69(1.00,2.86) 0.051
Employed 245 144 1.00 1.00
Presence of functional Radio Yes 204 174 2.04(1.55,2.69)* 1.52(0.88,2.61) 0.129
No 171 298 1.00 1.00
Presence of functional TV Yes 161 113 2.39(1.78,3.21)* 1.63(0.85,3.15) 0.142
No 214 359 1.00 1.00
Total number of living
children
None 43 104 1.00 1.00
1–2 children 211 234 2.18(1.46,3.26)** 2.46(1.19,5.11)* 0.015
3–4 children 98 109 2.18(1.39,3.40)* 4.06(1.57,10.48)* 0.004
5–7 children 23 25 2.23(1.14,4.34)* 3.95(1.05,14.90)* 0.043
Fertility intention Yes 193 201 1.43(1.09,1.88)* 0.66(0.35,1.22) 0.185
No 182 271 1.00 1.00
WHO clinical stage I 250 250 2.25(1.59, 3.17)** 1.17(0.60,2.31) 0.644
II 86 61 1.56(1.00, 2.43)* 1.04(0.45.2.40) 0.922
III or IV 141 64 1.00 1.00 1.00
Latest CD4 count ,200 55 89 1.00 1.00
.=200 & ,350 127 129 1.59(1.05,2.41)* 1.55(0.70,3.43) 0.278
.=350 447 254 1.23(0.84,1.81) 0.96(0.46,2.00) 0.912
Disclosed HIV status to
anybody
Yes 330 392 1.50(1.01,2.22)* 0.48(0.22,1.06) 0.07




Yes 366 418 5.25(2.56,10.79)* 2.67(0.85,8.33) 0.092
No 9 54 1.00 1.00




Yes 256 66 6.65(4.05,10.93)* 6.34(3.42,11.76)** ,0.001
No 35 60 1.00 1.00
COR-Crude Odds Ratio, AOR-Adjusted Odds Ratio,
*significant at P = 0.05,
**significant at P,0.001.
doi:10.1371/journal.pone.0094682.t003
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vertical transmission, and decrease incidence of conception-related
sexual transmission to discordant sexual partners [39].
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